REGN

REGN Operating Cash Flow Growth

-6.34%TTM

Period ending:

REGN TTM Cash from Operations YoY %%
REGN TTM Cash from Operations YoY %1280.73%-2837.25%
1993-06-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

REGN operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 133 observations from Jun 30, 1993 to Jun 30, 2026.

Regeneron Pharmaceuticals Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-6.3392%
26.8043%
12.6321%
19.3907%
16.5336%
-16.5819%
-3.7767%
-18.6976%
-14.1027%
10.7013%
-8.393%
-7.8218%
-43.9341%
-49.7234%
-29.1811%
-4.5843%
272.0322%
228.923%
170.4748%
173.157%
-23.9175%
16.0287%
7.7407%
-8.3031%
31.7203%
-9.7966%
10.7011%
16.6318%
13.6245%
57.5351%
67.9367%
81.8569%
47.3277%
-12.0108%
-11.2866%
-18.826%
-16.3618%
20.7657%
10.7167%
10.4406%
212.2183%
147.4118%
76.8631%
50.0686%
-31.689%
8.3957%
28.9193%
107.7332%
148.7345%
458.3305%
882.2127%
283.4117%
216.2857%
145.2336%
47.3363%
-63.9189%
-453.067%
-327.7899%
-247.0585%
-245.2046%
194.2779%
232.9479%
233.385%
248.6054%
15.567%
11.4956%
18.921%
-2,438.7402%
-428.6413%
-534.9276%
-425.464%
-108.1352%
10.4559%
118.6354%
18.6219%
159.6266%
151.2062%
114.7188%
176.1652%
-121.1012%
-347.152%
-267.0737%
-79.1709%
31.6576%
-134.8327%
234.3407%
-175.7052%
-279.5991%
134.1727%
68.889%
94.4509%
91.014%
0.8341%
-11.0687%
-92.8175%
-123.6647%
-269.6765%
-280.2079%
-105.3744%
-153.4189%

Compare operating cash flow growth

All REGN financial metrics · REGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.